Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 12/2015

01-12-2015 | Retinal Disorders

The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients

Authors: Chui Ming Gemmy Cheung, Elizabeth Yang, Won Ki Lee, Gary K. Y. Lee, Ranjana Mathur, Jacob Cheng, Doric Wong, Tien Yin Wong, Timothy Y. Y. Lai

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 12/2015

Login to get access

Abstract

Purpose

We aimed to evaluate the long-term natural history of polypoidal choroidal vasculopathy (PCV) in untreated patients.

Methods

This is a retrospective observational case series. Patients with symptomatic PCV who did not receive any treatment for at least 12 months were included from the records of three ophthalmic clinics in Asia. The medical records and imaging data were reviewed. Visual outcomes at month 12 and at last follow-up were analyzed. The influence of demographics and presenting features on visual outcome was analyzed.

Results

A total of 32 eyes (32 patients) were included in this analysis. The mean follow-up was 59.9 months (range, 18–119 months), the mean age was 65.7 years and 21 (65.6 %) patients were male. The mean presenting logMAR visual acuity was 0.79 (Standard deviation [SD] 0.49). The center of the fovea was involved by the PCV complex in 25 eyes (78.1 %). The mean greatest linear dimension (GLD) of the PCV complex was 2584 μm (SD 880). Twenty-three eyes (71.9 %) had a cluster-of-grapes configuration on indocyanine green angiography. Leakage of fluorescein angiography was present in 29 eyes (90.6 %). The mean logMAR vision deteriorated from 0.79 at baseline to 0.88 at month 12 (p = 0.11), and further to 1.14 (p = 0.003) at the last follow-up. The proportion of eyes that improved, remained unchanged and worsened was 21.9 %, 31.3 % and 46.9 %, respectively, at month 12; and 28.1 %, 9.4 % and 62.5 %, respectively, at last follow-up. The proportion of eyes with logMAR vision worse than 1.0 was 28.1 % at presentation, and increased to 31.3 % at month 12 and further to 53.1 % at last follow-up. Reasons for poor vision were due to retinal, subretinal or vitreous hemorrhage, and retinal pigment epithelium (RPE) atrophy and scarring. None of the presenting features were found to significantly influence visual outcome.

Conclusions

Half of eyes presenting with symptomatic PCV had a relatively benign course without treatment and some even had vision improvement. However, in the remaining eyes, vision deteriorated significantly, mainly due to hemorrhage and scarring. There may be subtypes of PCV with divergent natural history.
Literature
1.
go back to reference Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106–16CrossRefPubMed Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106–16CrossRefPubMed
2.
go back to reference Jonas JB (2014) Global prevalence of age-related macular degeneration. Lancet Glob Health 2:e65–6CrossRefPubMed Jonas JB (2014) Global prevalence of age-related macular degeneration. Lancet Glob Health 2:e65–6CrossRefPubMed
3.
go back to reference Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116–26CrossRefPubMed Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116–26CrossRefPubMed
4.
go back to reference Chakravarthy U, Evans J, Rosenfeld PJ (2010) Age related macular degeneration. BMJ 340:526–30CrossRef Chakravarthy U, Evans J, Rosenfeld PJ (2010) Age related macular degeneration. BMJ 340:526–30CrossRef
5.
go back to reference Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, Wong TY, Aung T (2009) Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? Prog Ret Eye Res 29:19–29CrossRef Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, Wong TY, Aung T (2009) Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? Prog Ret Eye Res 29:19–29CrossRef
6.
go back to reference Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF, Freund KB, Slakter JS, Guyer DR, Sorenson JA, Fisher Y, Maberley D, Orlock DA (1999) Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 117:1503–10CrossRefPubMed Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF, Freund KB, Slakter JS, Guyer DR, Sorenson JA, Fisher Y, Maberley D, Orlock DA (1999) Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 117:1503–10CrossRefPubMed
7.
go back to reference Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA (1997) The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115:478–85CrossRefPubMed Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA (1997) The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115:478–85CrossRefPubMed
8.
go back to reference Perkovich BT, Zakov ZN, Berlin LA, Weidenthal D, Avins LR (1990) An update on multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Retina 10:18–26CrossRefPubMed Perkovich BT, Zakov ZN, Berlin LA, Weidenthal D, Avins LR (1990) An update on multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Retina 10:18–26CrossRefPubMed
9.
go back to reference Okubo A, Arimura N, Abematsu N, Sakamoto T (2010) Predictive signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes. Acta Ophthalmol 88:e107–14CrossRefPubMed Okubo A, Arimura N, Abematsu N, Sakamoto T (2010) Predictive signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes. Acta Ophthalmol 88:e107–14CrossRefPubMed
10.
go back to reference Moorthy RS, Lyon AT, Rabb MF, Spaide RF, Yanuzzi LA, Jampol LM (1998) Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology 105:1380–5CrossRefPubMed Moorthy RS, Lyon AT, Rabb MF, Spaide RF, Yanuzzi LA, Jampol LM (1998) Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology 105:1380–5CrossRefPubMed
11.
go back to reference Yamaoka S, Okada AA, Sugahara M, Hida T (2010) Clinical features of polypoidal choroidal vasculopathy and visual outcomes in the absences of classic choroidal neovascularization. Ophthalmologica 224:147–52CrossRefPubMed Yamaoka S, Okada AA, Sugahara M, Hida T (2010) Clinical features of polypoidal choroidal vasculopathy and visual outcomes in the absences of classic choroidal neovascularization. Ophthalmologica 224:147–52CrossRefPubMed
12.
go back to reference Bessho H, Honda S, Imai H, Negi A (2011) Natural course and funduscopic findings of polypoidal choroidal vasculopathy in a Japanese population over 1 year of follow-up. Retina 31:501–15CrossRef Bessho H, Honda S, Imai H, Negi A (2011) Natural course and funduscopic findings of polypoidal choroidal vasculopathy in a Japanese population over 1 year of follow-up. Retina 31:501–15CrossRef
13.
go back to reference Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639–48CrossRefPubMed Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639–48CrossRefPubMed
14.
go back to reference Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T, Nishikawa M, Mitsuma Y, Yamazaki Y, Matsumura M, Uyama M (2003) Polypoidal choroidal vasculopathy. Incidence, demographic features and clinical characteristics. Arch Ophthalmol 121:1392–6CrossRefPubMed Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T, Nishikawa M, Mitsuma Y, Yamazaki Y, Matsumura M, Uyama M (2003) Polypoidal choroidal vasculopathy. Incidence, demographic features and clinical characteristics. Arch Ophthalmol 121:1392–6CrossRefPubMed
15.
go back to reference Okubo A, Sameshima M, Sakamoto T (2004) Plasticity of polypoidal lesions in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 242:962–5CrossRefPubMed Okubo A, Sameshima M, Sakamoto T (2004) Plasticity of polypoidal lesions in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 242:962–5CrossRefPubMed
16.
go back to reference Musashi K, Tsujikawa A, Hirami Y, Otani A, Yodoi Y, Tamura H, Yoshimura N (2007) Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy. Am J Ophthalmol 143:883–5CrossRefPubMed Musashi K, Tsujikawa A, Hirami Y, Otani A, Yodoi Y, Tamura H, Yoshimura N (2007) Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy. Am J Ophthalmol 143:883–5CrossRefPubMed
17.
go back to reference Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH (2004) Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy one-year results of a prospective case series. Ophthalmology 111:1576–1584CrossRefPubMed Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH (2004) Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy one-year results of a prospective case series. Ophthalmology 111:1576–1584CrossRefPubMed
18.
go back to reference Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Yano Y (2008) One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 115:141–146CrossRefPubMed Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Yano Y (2008) One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 115:141–146CrossRefPubMed
19.
go back to reference Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M, Tano Y (2008) Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 92:70–73CrossRefPubMed Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M, Tano Y (2008) Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 92:70–73CrossRefPubMed
20.
go back to reference Lai TY, Chan WM, Liu DT, Luk FO, Lam DS (2008) Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasclopathy. Br J Ophthalmol 92:661–666CrossRefPubMed Lai TY, Chan WM, Liu DT, Luk FO, Lam DS (2008) Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasclopathy. Br J Ophthalmol 92:661–666CrossRefPubMed
21.
go back to reference Cheung CM, Bhargava M, Laude A, Koh ACH, Xiang L, Wong D, Niang T, Lim TH, Gopal L, Wong TY et al (2012) Asian age-related macular degeneration phenotyping study: rationale, design and protocol of a prospective cohort study. Clin Exp Ophthalmol 40:727–35CrossRef Cheung CM, Bhargava M, Laude A, Koh ACH, Xiang L, Wong D, Niang T, Lim TH, Gopal L, Wong TY et al (2012) Asian age-related macular degeneration phenotyping study: rationale, design and protocol of a prospective cohort study. Clin Exp Ophthalmol 40:727–35CrossRef
23.
go back to reference Pauleikoff D, Löffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A, Bird AC (2002) Pigment epitheilial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240:533–8CrossRef Pauleikoff D, Löffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A, Bird AC (2002) Pigment epitheilial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240:533–8CrossRef
24.
go back to reference Lee WK, Kim KS, Kim W, Lee SB, Jeon S (2012) Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters. Am J Ophthalmol 154:355–65CrossRefPubMed Lee WK, Kim KS, Kim W, Lee SB, Jeon S (2012) Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters. Am J Ophthalmol 154:355–65CrossRefPubMed
25.
go back to reference Cackett P, Wong D, Yeo I (2009) A classification system for polypoidal choroidal vasculopathy. Retina 29:187–91CrossRefPubMed Cackett P, Wong D, Yeo I (2009) A classification system for polypoidal choroidal vasculopathy. Retina 29:187–91CrossRefPubMed
27.
go back to reference Byeon SH, Lew YJ, Lee SC, Kwon OW (2010) Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. Acta Ophthalmol 88:660–8CrossRefPubMed Byeon SH, Lew YJ, Lee SC, Kwon OW (2010) Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. Acta Ophthalmol 88:660–8CrossRefPubMed
28.
go back to reference Okubo A, Ito M, Sameshima M, Uemura A, Sakamoto T (2005) Pulsatile blood flow in the polypoidal choroidal vasculopathy. Ophthalmology 112:1436–41CrossRefPubMed Okubo A, Ito M, Sameshima M, Uemura A, Sakamoto T (2005) Pulsatile blood flow in the polypoidal choroidal vasculopathy. Ophthalmology 112:1436–41CrossRefPubMed
29.
go back to reference Koh A, Lee WK, Chen LJ et al (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453–64CrossRefPubMed Koh A, Lee WK, Chen LJ et al (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453–64CrossRefPubMed
30.
go back to reference Uyama M, Matsubara T, Fukushima I, Matsunaga H, Iwashita K, Nagai Y, Takahashi K (1999) Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 117:1035–42CrossRefPubMed Uyama M, Matsubara T, Fukushima I, Matsunaga H, Iwashita K, Nagai Y, Takahashi K (1999) Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 117:1035–42CrossRefPubMed
31.
go back to reference Okubo A, Hirakawa M, Ito M, Samehima M, Sakamoto T (2008) Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration. Graefes Arch Clin Exp Ophthalmol 246:491–9CrossRefPubMed Okubo A, Hirakawa M, Ito M, Samehima M, Sakamoto T (2008) Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration. Graefes Arch Clin Exp Ophthalmol 246:491–9CrossRefPubMed
32.
go back to reference Tamura H, Tsujikawa A, Otani A et al (2007) Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularization on fluorescein angiography. Br J Ophthalmol 91:1152–9PubMedCentralCrossRefPubMed Tamura H, Tsujikawa A, Otani A et al (2007) Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularization on fluorescein angiography. Br J Ophthalmol 91:1152–9PubMedCentralCrossRefPubMed
33.
go back to reference Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15–22CrossRefPubMed Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15–22CrossRefPubMed
34.
go back to reference Maruko I, Iida T, Saito M, Nagayama D (2010) Combined cases of polypoidal choroidal vasculopathy and typeical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 248:361–8CrossRefPubMed Maruko I, Iida T, Saito M, Nagayama D (2010) Combined cases of polypoidal choroidal vasculopathy and typeical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 248:361–8CrossRefPubMed
Metadata
Title
The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients
Authors
Chui Ming Gemmy Cheung
Elizabeth Yang
Won Ki Lee
Gary K. Y. Lee
Ranjana Mathur
Jacob Cheng
Doric Wong
Tien Yin Wong
Timothy Y. Y. Lai
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 12/2015
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-2933-2

Other articles of this Issue 12/2015

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2015 Go to the issue